Gabelli & Co Investment Advisers’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-182,618	Closed	-$6.17M	–	584
2021 Q2	$6.17M	Buy	+182,618	New	+$4.65M	0.71%	34

Gabelli & Co Investment Advisers's CNST Position: Q3 2021 in Review

Gabelli & Co Investment Advisers sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 182,618 shares — an estimated $6.17M sold.

Gabelli & Co Investment Advisers first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $6.17M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Gabelli & Co Investment Advisers reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 182,618 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $6.17M.
Gabelli & Co Investment Advisers first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Constellation Pharmaceuticals, Inc. position peaked at $6.17M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.